SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Future trends: Rise of mAbs and fall of 20,000L bioreactors says consultant

Increased efficiency, local manufacturing and specialty products are driving demand for smaller more flexible facilities, according to bioprocessing consultant Howard Levine.

editor's blog

Walk like an Egyptian? Not if you have ankylosing spondylitis says study

Ramesses II would not have been helped by Enbrel, Remicade or Humira according to a study refuting the idea the pharaohs were plagued, all puns intended, by ankylosing spondylitis.

EC Oks 'dead' Abbvie-Shire takeover deal

Great news Abbvie; the European Commission (EC) has no problem with you buying Shire. 

Lilly to shutter Puerto Rican plant as focus moves to insulin and biologics

An Eli Lilly small molecule plant in Puerto Rico has been earmarked for closure as the company shifts its focus towards its insulin and biologics pipeline.

Janssen confident of Remicade sales despite growing biosimilar threat

Remicade has clocked up $3.1bn in sales so far this year and Janssen is confident of more despite the growing threat of biosimilar competition.

MedImmune teams with UK academics on neurodegenerative disease research

MedImmune’s neurodegenerative disease partnership with the University of Cambridge is about working with “great scientists with great brains” according to a spokeswoman for parent company, AstraZeneca.

Spotlight

Greenpeace: Industry needs greener disposal for single-use systems

Greenpeace: Industry needs greener disposal methods for single-use systems

Common environmentally practices for single-use systems must be adapted before industry “becomes too set in its ways,”...

Seattle Genetics, Genmab enter ADC collaboration worth up to $211m

Seattle Genetics, Genmab enter ADC collaboration worth up to $211m

Seattle Genetics and Genmab have entered into another antibody-drug conjugate (ADC)partnership under which Genmab will pay $11m...

Purple not the new orange: US FDA biopharmaceuticals list lacks dates

Purple not yet the new orange: US FDA biopharmaceuticals list lacks dates

A new list of biopharmaceuticals published by the US FDA provides limited information with only the entries...

Better together? Biosimilars sector says aye
infographic feature

Better together? biosimilars sector says aye

Partnerships are a mixed bag.For every oppressed group yearning to throw off the yoke of their imperialist...

Shifting pipelines drive AMRI to expand protein expression services

Shifting pipelines drive AMRI to expand protein expression services

AMRI has added protein expression and purification services to its drug discovery services citing the shift in...

Asthma: It’s a mAb, mAb, mAb, mAb world says analyst

Asthma: It’s a mAb, mAb, mAb, mAb world says analyst

Sanofi and Regeneron may overtake Roche and Astrazeneca at the head of the increasingly monoclonal antibody (mAb)...

On demand Supplier Webinars

Biosimilars: developing, manufacturing and selling
William Reed Business Media
All supplier webinars